scorecardresearch
Add as a preferred source on Google
Saturday, November 29, 2025
TopicDiabetes

Topic: Diabetes

Fat-busting drug Mounjaro launched in India. Here’s how much it will cost

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, it has since become a global blockbuster.

Swapping ghar ka khaana with ready-to-eat foods? 66% beverages have high sugar, 97% snacks high fat

Govt-funded study analysed front and back of labels of 432 popular packaged food products including breakfast cereals, idli mixes, porridges, soup mixes, beverages and extruded snacks.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

India had highest number of diabetics in the world in 2022, 62% were not on medication—Lancet report

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both diabetes rates and treatment across countries.

Danish scientists create ‘smart’ insulin with ‘on-off’ switch to target blood sugar highs & lows

Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

Fried, baked, ultra-processed foods fuel India’s diabetes epidemic—1st-of-its-kind study by ICMR & MDRF

Study published in International Journal of Food Sciences and Nutrition says having foods low in advanced glycation end products can mitigate burden of obesity-linked type 2 diabetes.

How semaglutide is emerging as A-Z drug, helping with diabetes, alcohol cravings & more

Health experts are now looking at whether semaglutide can also curb alcohol cravings among addicts. A look at how this GLP-1 category drug functions in humans.

Chinese scientists see sweet success, reverse type-1 diabetes in woman using her own stem cells

Study in journal Cell says fat cells were extracted from the patient & altered to develop into any type of cell in the body. She has been insulin-independent for a yr, the 1st such case.

Yoga, dual therapies — 1st India-specific guidelines for those with both hypertension & diabetes

Key feature of guidelines is emphasis on using multiple methods to measure hypertension, including home BP monitoring. For the first time, yoga is recommended as an adjunct therapy

Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year

Tirzepatide is a type 2 diabetes and obesity drug sold by US firm Eli Lilly under the brand names Mounjaro and Zepbound. It may take around 6 months for it to be launched in India.

On Camera

‘Delhi winters’ is a legend. Now it’s just air anxiety

The wealthy float above the crisis—insulated in air-purified cars, weekend getaways at farmhouses, and vacations timed perfectly to coincide with Delhi’s worst weeks.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.